The Joint Council for Cosmetic Practitioners (JCCP) has published new guidance for responsible prescribing for cosmetic practitioners.
Clinic group Tinkable Aesthetic Clinic has introduced a new business opportunity that is similar to a franchise scheme for aesthetic medical professionals called the Tinkable License.
US-based medical aesthetic company Evolus Inc has begun a consumer campaign in the US called ‘#NEWTOX NOW’ in the hope to encourage patients to use its botulinum toxin.
On May 14, pharmaceutical company Galderma (UK) Limited celebrated 10 years since Azzalure®(AbobotulinumtoxinA) was first approved in Europe for the treatment of glabellar lines.
The Joint Council for Cosmetic Practitioners (JCCP) has released its annual report showcasing its achievements the not-for-profit organisation has attained within the last year.
The results of two studies conducted by pharmaceutical company Galderma (UK) Limited have demonstrated high patient satisfaction for the use of Azzalure (AbobotulinumtoxinA), its botulinum toxin type A product, in the glabellar complex.
For a third year, practitioners were invited by training provider Cosmetic Courses to attend a full day of learning at the Royal Society of Medicine.
A national petition to make dermal fillers prescription only and the relevant insurance required to access them mandatory has been launched by the Joint Council of Cosmetic Practitioner (JCCP).
Nurse prescriber Sandy Green will host a half-hour Expert Clinic session from 2pm on Saturday March 2 at the Aesthetics Conference and Exhibition (ACE) 2019.
Independent accreditation body Save Face has published its consumer complaints audit report for 2017-2018.